Core Viewpoint - PepsiCo has been experiencing a decline in stock performance, with a return of -9.1% over the past month, significantly underperforming the S&P 500 composite's -0.7% change and the Zacks Beverages - Soft drinks industry's -1.4% loss [2] Earnings Estimates Revisions - For the current quarter, PepsiCo is expected to report earnings of $2.08 per share, reflecting an -8.8% change from the previous year, with the Zacks Consensus Estimate decreasing by -10.4% over the last 30 days [5] - The consensus earnings estimate for the current fiscal year is $7.93, indicating a -2.8% change from the prior year, with a -4.8% revision in the last month [5] - For the next fiscal year, the consensus estimate is $8.39, showing a +5.8% change from the previous year, although this estimate has also changed by -4.8% recently [6] - PepsiCo holds a Zacks Rank 4 (Sell) due to significant changes in earnings estimates and other related factors [7] Revenue Growth Forecast - The consensus sales estimate for the current quarter is $22.39 billion, indicating a -0.5% year-over-year change [11] - For the current fiscal year, the sales estimate is $92.22 billion, reflecting a +0.4% change, while the next fiscal year's estimate is $95.28 billion, indicating a +3.3% change [11] Last Reported Results and Surprise History - In the last reported quarter, PepsiCo's revenues were $17.92 billion, down -1.8% year-over-year, with an EPS of $1.48 compared to $1.61 a year ago [12] - The reported revenues exceeded the Zacks Consensus Estimate of $17.75 billion by +0.94%, while the EPS fell short by -1.33% [12] - Over the last four quarters, PepsiCo surpassed consensus EPS estimates three times but only exceeded revenue estimates once [13] Valuation - PepsiCo's valuation metrics indicate that it is trading at a premium to its peers, receiving a Zacks Value Style Score of D, suggesting it may be overvalued [17]

Core Viewpoint - Adma Biologics has shown strong stock performance recently, with a +17.7% return over the past month, contrasting with the S&P 500's -0.7% change, indicating potential investor interest and market momentum [2]. Earnings Estimate Revisions - The consensus earnings estimate for Adma Biologics is $0.16 per share for the current quarter, reflecting a year-over-year increase of +100% [5]. - For the current fiscal year, the consensus earnings estimate stands at $0.71, indicating a year-over-year change of +44.9% [5]. - The next fiscal year's consensus earnings estimate is $0.93, representing a +31% change from the previous year [6]. - The Zacks Rank for Adma Biologics is 2 (Buy), suggesting a favorable outlook based on earnings estimate revisions [7]. Revenue Growth Forecast - The consensus sales estimate for the current quarter is $119.1 million, indicating a year-over-year increase of +45.5% [11]. - For the current fiscal year, the sales estimate is $495.8 million, reflecting a +16.3% change, while the next fiscal year's estimate is $611.5 million, indicating a +23.3% change [11]. Last Reported Results and Surprise History - In the last reported quarter, Adma Biologics generated revenues of $117.55 million, a year-over-year increase of +59.1% [12]. - The EPS for the same period was $0.14, compared to $0.04 a year ago, with a revenue surprise of +4.77% against the Zacks Consensus Estimate [12]. - Over the last four quarters, the company has surpassed consensus EPS estimates three times and topped revenue estimates each time [13]. Valuation - Adma Biologics has a Zacks Value Style Score of D, indicating it is trading at a premium compared to its peers [17].

Core Viewpoint - CyberArk (CYBR) has been trending on Zacks.com, indicating potential interest in its stock performance in the near term [1] Earnings Estimate Revisions - CyberArk is expected to report earnings of $0.79 per share for the current quarter, reflecting a year-over-year increase of +5.3% [5] - The consensus earnings estimate for the current fiscal year is $3.65, indicating a +20.5% change from the previous year, with a recent upward revision of +9.6% [5] - For the next fiscal year, the earnings estimate is $4.65, suggesting a +27.3% increase from the prior year, with a slight upward revision of +0.7% [6] - The Zacks Rank for CyberArk is 2 (Buy), indicating a favorable outlook based on earnings estimate revisions [7] Revenue Growth Forecast - The consensus sales estimate for the current quarter is $305.66 million, representing a year-over-year increase of +38% [11] - For the current fiscal year, the revenue estimate is $1.31 billion, indicating a +31.3% change, while the next fiscal year's estimate is $1.57 billion, reflecting a +19.1% change [11] Last Reported Results and Surprise History - In the last reported quarter, CyberArk achieved revenues of $314.38 million, a +40.9% year-over-year increase, and an EPS of $0.80, slightly down from $0.81 a year ago [12] - The company exceeded the Zacks Consensus Estimate for revenues by +4.43% and for EPS by +12.68% [12] - CyberArk has consistently beaten consensus EPS and revenue estimates over the last four quarters [13] Valuation - CyberArk is graded F on the Zacks Value Style Score, indicating it is trading at a premium compared to its peers [17] - Valuation multiples such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF) are essential for assessing whether the stock is overvalued or undervalued [15][16] Bottom Line - The information presented suggests that CyberArk may outperform the broader market in the near term, supported by its Zacks Rank 2 [18]

Core Viewpoint - Qorvo's stock experienced a significant increase following the release of its fiscal Q4 2025 earnings report, which exceeded analyst expectations despite a year-over-year decline in sales [1][2]. Financial Performance - Qorvo reported earnings of $1.42 per share, surpassing the analyst forecast of $1 per share, with sales reaching $869.5 million compared to the expected $850.5 million [1][2]. - The company's sales declined by 7.6% year over year, but gross profit margins improved by 160 basis points to 42.2% [2]. - Net income rose dramatically from $0.03 per share a year ago to $0.33 per share under GAAP, indicating a significant improvement [3]. - Qorvo generated $171 million in positive free cash flow for the quarter and $485 million for the entire fiscal year 2025 [3]. Market Outlook - Despite the positive earnings report, management forecasted only $775 million in sales for fiscal Q1 2026, which represents a 13% decline compared to the same quarter last year, suggesting worsening business conditions [5]. - The projected gross margins for the upcoming quarter are estimated to be between 42% and 44%, but this is a non-GAAP estimate, leaving uncertainty regarding actual GAAP margins [5]. - The stock appears undervalued with a price-to-free cash flow ratio of approximately 12x, but caution is advised before making investment decisions based solely on valuation [4].

Core Viewpoint - Following a strong earnings report, Netflix's stock has surged over 22% year-to-date, significantly outperforming the S&P 500's decline of nearly 7% [1] Group 1: Financial Performance - In the first quarter, Netflix's revenue grew by approximately 12.5% year-over-year, while operating income increased by 27.1%, both exceeding management's guidance [3] - Management anticipates second-quarter revenue growth of 15.4% year-over-year, an acceleration from the first quarter's growth rate [7] - Operating margin is expected to expand to 33.3% in the second quarter, up from 27.2% in the same period last year [7] - Forecasts indicate a 41% year-over-year increase in operating income for the second quarter of 2025 [8] Group 2: Advertising Business - Netflix's advertising business is seen as a significant growth opportunity, with expectations for advertising revenue to "roughly double" this year [4] - The small size of the advertising business relative to overall sales provides some insulation against macroeconomic uncertainties [4][5] Group 3: Share Repurchase and Valuation - The company has aggressively repurchased shares, spending $3.7 billion in the first quarter, significantly more than the $800 million used to pay down debt [6] - Current valuation stands at a price-to-earnings multiple of 52, reflecting strong earnings momentum and growth potential [9] - High valuation may limit room for risks, suggesting that investors might consider waiting for a better entry point [10] Group 4: Investment Recommendation - For existing shareholders, the positive updates from Netflix provide reasons to hold the stock despite its high valuation [11] - There is no compelling reason to sell at this time, placing shares in a hold recommendation [11]

The stock market is in turmoil due to tariffs this year, and one sector that's taking a big hit is retail. The SPDR S&P Retail ETF has declined by more than 14% since January, as investors worry about rising costs yet again for many retailers. Even if prices don't increase, a recession could lead to consumers pulling back on purchases. Skipping a trip to Costco can sometimes be an easy way to save money by avoiding the temptation to purchase a lot more than you intended. If consumers do that and Costco's gr ...

GE Vernova (GEV) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares of this the energy business spun off from General Electric have returned +21.2% over the past month versus the Zacks S&P 500 composite's -0.8% change. The Zacks Alternative Energy - Other industry, to which GE Vernova belongs, has gained 2.8% over this period. Now the key question is: Where could the stock ...

Core Viewpoint - Chipotle's stock has declined over 25% since the appointment of new CEO Scott Boatwright, raising concerns about the company's future performance and growth potential [1][7]. Current State of Chipotle - The company reported a 0.4% decrease in annual comparable-restaurant sales for Q1 2025, a significant drop from the 7.4% increase in 2024 and 5.4% in Q4 2024, attributed to consumer uncertainty [4]. - Chipotle expanded its restaurant count to 3,781, marking an 8% increase with 302 new locations over the past year, and reported Q1 revenue of $2.9 billion, reflecting a 6.4% increase [5]. - The operating margin improved to 16.7% from 16.3% year-over-year, resulting in a net income of $387 million, an 8% annual gain [5]. Growth Projections - The company anticipates comparable-restaurant sales growth to remain in the "low single digits" for the year, leading to concerns among shareholders about future growth rates [6]. Investment Case Assessment - Historically, Chipotle's stock outperformed the S&P 500, but it has declined 15% over the past 12 months, particularly after the leadership change [7]. - The current price-to-earnings (P/E) ratio stands at 45, which is at the lower end of its five-year range, raising concerns about valuation amidst slowing growth [8]. - Comparatively, mature restaurant stocks like McDonald's and Starbucks trade at P/E ratios of 28 and 27, respectively, suggesting potential valuation compression for Chipotle if growth does not rebound [9][10]. Future Expansion Plans - Chipotle plans to open 315 to 345 new locations in 2025 and is exploring opportunities in Mexico, indicating a commitment to maintaining its expansion trajectory [12]. - The smaller size of Chipotle compared to larger peers may allow for higher percentage growth in its footprint [11]. Investment Recommendation - The current recommendation is to hold Chipotle stock, as it presents a compelling value proposition amid ongoing expansion, despite uncertainties related to leadership changes and economic conditions [13]. - Investors may want to wait for a more favorable entry point or clearer growth prospects before increasing their positions in Chipotle [14].

Shopify (SHOP) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.Over the past month, shares of this cloud-based commerce company have returned +0.5%, compared to the Zacks S&P 500 composite's -4.3% change. During this period, the Zacks Internet - Services industry, which Shopify falls in, has lost 5.1%. The key question now is: What could be the stock's future direc ...

Core Insights - Moody's reported an 8% year-over-year increase in quarterly revenue and a 14% rise in adjusted earnings per share (EPS) to $3.83, exceeding Wall Street estimates [1] - However, the company revised its full-year profit guidance downward, contributing to a 19% decline in its stock from the 52-week high amid economic uncertainties [2] Financial Performance - The company has a strong financial analytics technology platform, benefiting from a trend where corporations and institutions outsource parts of their investing workflow [3] - Moody's experienced robust demand for cloud-based subscriptions and data licensing, starting fiscal 2025 with strong performance [4] - The Moody's Investor Service segment saw an 8% year-over-year revenue increase due to momentum in global bond issuances and favorable market conditions [6] - Moody's Analytics group reported a 9% increase in annualized recurring revenue (ARR) and a 93% retention rate, indicating durable growth [7] - The adjusted operating margin reached 51.7%, up 100 basis points year-over-year, and the company increased its dividend by 11% to $0.94 per share, yielding 0.9% [8] Outlook and Guidance - Moody's faces challenges from a rapidly evolving operating environment, particularly due to recent changes in U.S. trade policy that may disrupt the economy [9] - A slowdown in global debt issuances could impact the credit ratings business and limit growth opportunities, leading to a tempered full-year growth and earnings outlook [10] - The revenue growth estimate for 2025 was revised from high single digits to mid-single digits, and adjusted EPS guidance was lowered to a range of $13.25 to $14 [11] - Despite solid fundamentals, the stock's valuation premium is difficult to justify, trading at a P/E ratio of 38, above the five-year average of around 35 [12] Investment Perspective - Current shareholders may find enough strong points to hold, but investors on the sidelines may discover better value and upside potential elsewhere in the market [14]